The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis
- PMID: 29565179
- PMCID: PMC6087895
- DOI: 10.1152/ajplung.00395.2017
The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis
Abstract
The common gain-of-function MUC5B promoter variant ( rs35705950 ) is the strongest risk factor for the development of idiopathic pulmonary fibrosis (IPF). While the role of complement in IPF is controversial, both MUC5B and the complement system play a role in lung host defense. The aim of this study was to evaluate the relationship between complement component 3 (C3) and MUC5B in patients with IPF and in bleomycin-induced lung injury in mice. To do this, we evaluated C3 gene expression in whole lung tissue from 300 subjects with IPF and 175 healthy controls. Expression of C3 was higher in IPF than healthy controls {1.40-fold increase [95% confidence interval (CI) 1.31-1.50]; P < 0.0001} and even greater among IPF subjects with the highest-risk IPF MUC5B promoter genotype [TT vs. GG = 1.59-fold (95% CI 1.15-2.20); P < 0.05; TT vs. GT = 1.66-fold (95% CI 1.20-2.30); P < 0.05]. Among subjects with IPF, C3 expression was significantly higher in the lung tissue without microscopic honeycombing than in the lung tissue with microscopic honeycombing [1.40-fold increase (95% CI 1.23- 1.59); P < 0.01]. In mice, while bleomycin exposure increased Muc5b protein expression, C3-deficient mice were protected from bleomycin-induced lung injury. In aggregate, our findings indicate that the MUC5B promoter variant is associated with higher C3 expression and suggest that the complement system may contribute to the pathogenesis of IPF.
Keywords: MUC5B; complement component 3; host defense; idiopathic pulmonary fibrosis.
Figures
Similar articles
-
Genes, other than Muc5b, play a role in bleomycin-induced lung fibrosis.Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L440-L450. doi: 10.1152/ajplung.00615.2020. Epub 2021 Jun 23. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 34160296 Free PMC article.
-
Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant.Cells. 2024 Sep 11;13(18):1523. doi: 10.3390/cells13181523. Cells. 2024. PMID: 39329706 Free PMC article.
-
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.Respir Res. 2021 Apr 1;22(1):98. doi: 10.1186/s12931-021-01694-z. Respir Res. 2021. PMID: 33794872 Free PMC article.
-
Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.Ann Am Thorac Soc. 2018 Nov;15(Suppl 3):S192-S197. doi: 10.1513/AnnalsATS.201802-144AW. Ann Am Thorac Soc. 2018. PMID: 30431344 Free PMC article. Review.
-
The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B.Biomed Res Int. 2019 Jun 11;2019:9712464. doi: 10.1155/2019/9712464. eCollection 2019. Biomed Res Int. 2019. PMID: 31309122 Free PMC article. Review.
Cited by
-
A role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis.Front Med (Lausanne). 2023 Aug 9;10:1236495. doi: 10.3389/fmed.2023.1236495. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37621463 Free PMC article.
-
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease.Open Access Rheumatol. 2023 May 15;15:65-79. doi: 10.2147/OARRR.S318826. eCollection 2023. Open Access Rheumatol. 2023. PMID: 37214353 Free PMC article. Review.
-
Lung epithelial cell-derived C3 protects against pneumonia-induced lung injury.Sci Immunol. 2023 Feb 3;8(80):eabp9547. doi: 10.1126/sciimmunol.abp9547. Epub 2023 Feb 3. Sci Immunol. 2023. PMID: 36735773 Free PMC article.
-
siRNA-Mediated Timp1 Silencing Inhibited the Inflammatory Phenotype during Acute Lung Injury.Int J Mol Sci. 2023 Jan 13;24(2):1641. doi: 10.3390/ijms24021641. Int J Mol Sci. 2023. PMID: 36675165 Free PMC article.
-
Our Compliments to the Authors: Decay Accelerating Factor and the Complement System in Pulmonary Fibrosis.Am J Respir Cell Mol Biol. 2022 Oct;67(4):415-416. doi: 10.1165/rcmb.2022-0268ED. Am J Respir Cell Mol Biol. 2022. PMID: 35901283 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous